OKLO

Two things landed at once. The company announced a $1 billion at-the-market equity offering in mid-September, which means new shares are sold into the market over time and existing holders are diluted. Around the same time, investors rotated out of nuclear names broadly, and Oklo fell 5% in a session when the group dropped 7%. That combination took the stock toward its 52-week low and undid much of the gain that had followed earlier policy support for nuclear power.

Not yet. The approval covers the preliminary safety analysis for the Aurora reactor, which is a meaningful step in the regulatory process and shows the design is being taken seriously. But the company still has no operating power generation, full design approval is outstanding, and commercial reactors are not expected until 2027-2028. Treat the milestone as progress on a long road rather than a green light for revenue.

It centres on demand rather than current output. Oklo sells small modular reactors directly to AI and data-centre operators, a customer group with rapidly growing electricity needs, which makes it a direct play on data-centre power rather than a supplier several steps removed. Supporters also point to its small market capitalisation and the possibility of large long-run gains if the technology deploys at scale. European government funding for SMR projects, including a €40M EIB loan, adds to the evidence that such reactors are moving from concept toward construction.

On the constructive side, a new data-centre supply agreement or a policy announcement that speeds deployment would give the stock something concrete to price, and so would evidence that the share sale is largely absorbed. On the negative side, a sustained break below the recent lows would suggest the selling is not finished, and any further capital raise would revive dilution worries. Watch the nuclear sector's direction too, since group rotation has moved this stock as much as its own news.